Joel Greenblatt | Gotham Asset Management, Llc

Fund Stats for Q2 2016Joel Greenblatt is the managing partner of Gotham Asset Management, Llc. The 13F filing for 2016 Q2 included $8.34B in managed 13F securities and a top 10 holdings concentration of 9.01%. Gotham Asset Management, Llc's largest holding is Biogen Inc. with shares held of 368.10K. 10kreader has 37 13F filings available for Gotham Asset Management, Llc.Joel Greenblatt is the managing partner of Gotham Asset Management, Llc. The 13F filing for 2016 Q2 included $8.34B in managed 13F securities and a top 10 holdings concentration of 9.01%. Gotham Asset...

About Joel GreenblattKnown for the invention of Magic Formula Investing, and founder of the New York Securities Auction Corporation (NYSAC), Greenblatt is founder and managing partner of Gotham Asset Management, LLC. He is the author of two investment books, including 'The Little Book that Beats the Market.' He is also an Adjunct Professor with Columbia Business School.Greenblatt tries to find cheap and good companies. He looks for value with a catalyst, so nice things happen sooner. Greenblatt likes special situations, and thinks that they are simply different places to find cheap stocks. In his own hedge fund, Greenblatt uses the basic principals in the Magic Formula: Look for high ROC and high earnings yield. He tries to figure out what 'normalized earnings' will be 3-4 years into the future. Greenblatt makes sure the stock is very cheap based on normalized earnings.source: gurufocus.comKnown for the invention of Magic Formula Investing, and founder of the New York Securities Auction Corporation (NYSAC), Greenblatt is founder and managing partner of Gotham Asset Management, LLC. He i...

Go to:

Company	Ticker	Market Value	% Portfolio	Shares	Change	Chg. Shares	Quarter End Price	Current Price	Yearly High	Yearly Low	Market Cap	% Owned
Biogen Inc.	BIIB	89.01M	1.07%	368.10K	23.24%	69.42K	$241.82	$206.72	$304.21	$187.16	30.00B	0.25%
Gilead Sciences, Inc.	GILD	84.77M	1.02%	1.02M	5.01%	48.50K	$83.42	$65.00	$74.12	$57.17	81.47B	0.08%
Twenty First Centy Fox Inc		76.34M	0.92%	2.82M	New	2.82M	$27.05
Apple Inc.	AAPL	74.49M	0.89%	779.16K	7.40%	53.67K	$95.60	$152.37	$182.94	$129.04	2.50T	0.00%
Amgen Inc.	AMGN	73.94M	0.89%	485.93K	50.26%	162.53K	$152.15	$227.66	$258.45	$198.64	121.78B	0.09%
Express Scripts Hldg Co		72.99M	0.88%	962.98K	-16.87%	-195.45K	$75.80
HCA Healthcare, Inc.	HCA	70.59M	0.85%	916.67K	47.32%	294.44K	$77.01	$208.97	$279.02	$164.47	59.98B	0.32%
Cbs Corp New		70.07M	0.84%	1.29M	287.14%	954.70K	$54.44
eBay Inc.	EBAY	69.91M	0.84%	2.99M	4.99%	142.01K	$23.41	$42.66	$81.19	$40.52	23.44B	0.54%
United Technologies Corp		69.25M	0.83%	675.24K	-21.42%	-184.04K	$102.55
Pfizer Inc.	PFE	68.25M	0.82%	1.94M	22.89%	361.02K	$35.21	$45.94	$61.71	$40.94	257.83B	0.03%
The J. M. Smucker Company	SJM	67.75M	0.81%	444.50K	29.27%	100.64K	$152.41	$139.15	$146.74	$119.09	14.83B	0.42%
Conagra Brands, Inc.	CAG	66.31M	0.79%	1.39M	New	1.39M	$47.81	$33.62	$36.97	$30.06	16.16B	0.29%
Oracle Corporation	ORCL	62.92M	0.75%	1.54M	173.25%	974.64K	$40.93	$70.24	$106.34	$63.76	189.34B	0.06%
CVS Health Corporation	CVS	62.42M	0.75%	652.00K	196.03%	431.75K	$95.74	$102.31	$111.25	$81.78	134.32B	0.05%
Cisco Systems, Inc.	CSCO	61.73M	0.74%	2.15M	18.16%	330.75K	$28.69	$43.29	$64.29	$40.82	177.87B	0.05%
Zimmer Biomet Holdings, Inc.	ZBH	61.25M	0.73%	508.83K	244.96%	361.33K	$120.38	$115.77	$149.28156	$100.39	24.29B	0.24%
Cardinal Health, Inc.	CAH	59.94M	0.72%	768.37K	222.18%	529.88K	$78.01	$66.39	$72.28	$45.85	18.09B	0.28%
QUALCOMM Incorporated	QCOM	59.91M	0.72%	1.12M	3.79%	40.80K	$53.57	$124.98	$193.58	$118.23	140.35B	0.10%
Intuit Inc.	INTU	56.76M	0.68%	508.59K	New	508.59K	$111.61	$422.12	$716.86	$339.36	118.98B	0.18%

Holdings Breakdown

Disclaimer: Investor holdings are derived from 13F filings which are required to be filed by all institutional investment managers with at least $100 million in assets under management. Limitations to this data include but are not limited to: (1) SEC does not review 13Fs for accuracy or completeness, (2) cash, foreign stocks, short positions, and a variety of other assets are not required to be reported, (3) 13Fs are often filed 45 days after the end of the quarter, by which time a manager's positions and outlook could have changed significantly, (4) the market value does not tell us at what price the manager acquired the asset, and (5) data is only available starting mid 2013. Please do your own research before drawing any conclusions from this data.